Amneal raises 2026 guidance on Q3 revenue growth, Kashiv integration progressNov 3Quarterly updateAmneal Pharmaceuticals, LLCXeris Biopharma Holdings, Inc.
Xeris reports second-quarter 2026 results, tightens full-year revenue guidanceAug 6Quarterly updatelevoketoconazoleXeris Biopharma Holdings, Inc.
Palvella Therapeutics adds Matthew Pauls to board of directorsJun 30PeoplePieris Pharmaceuticals, Inc.